Compare DexCom, Inc. (DXCM) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs 10X Genomics Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while 10X Genomics Inc trades at $58.56 (market cap $7.61B). The key difference: DexCom, Inc. is far larger — about 4.4× 10X Genomics Inc's market cap. Which is the better fit depends on your goals.
| DXCM | TXG | |
|---|---|---|
Market Cap | $33.79B | $7.61B |
Sector | Health | Health |
52-Week High | $89.53 | $58.57 |
52-Week Low | $54.84 | $11.34 |
Enterprise Value | $33.24B | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
